Unfolding dermatologic spectrum of Behçet’s disease in Italy: real-life data from the International AIDA Network Behçet’s disease Registry

被引:0
作者
Martina D’Onghia
Elisa Cinotti
Alessandra Cartocci
Antonio Vitale
Valeria Caggiano
Linda Tognetti
Francesca La Marca
Jurgen Sota
Stefano Gentileschi
Giovanni Rubegni
Giuseppe Lopalco
Silvana Guerriero
Marcello Govoni
Sara Monti
Piero Ruscitti
Fabrizio Angeli
Francesco Carubbi
Roberto Giacomelli
Francesco Ciccia
Matteo Piga
Giacomo Emmi
Stefania Costi
Gian Domenico Sebastiani
Florenzo Iannone
Veronica Spedicato
Giovanni Alessio
Francesca Ruffilli
Alessandra Milanesi
Martina Gentile
Francesca Crisafulli
Alessia Alunno
Luca Navarini
Daniela Iacono
Alberto Cauli
Francesca Ricci
Carla Gaggiano
Maria Tarsia
Elena Bartoloni
Giovanni Conti
Ombretta Viapiana
Francesca Li Gobbi
Amato de Paulis
Paola Parronchi
Emanuela Del Giudice
Patrizia Barone
Alma Nunzia Olivieri
Emanuele Bizzi
Maria Cristina Maggio
Alberto Balistreri
Bruno Frediani
机构
[1] University of Siena,Unit of Dermatology, Department of Medical, Surgical and Neurological Science
[2] University of Siena,Department of Medical Biotechnologies
[3] Research Center of Systemic Autoinflammatory Diseases and Behçet’s Disease Clinic,Department of Medical Sciences, Surgery and Neurosciences
[4] University of Siena,Department of Ophthalmology
[5] Azienda Ospedaliero-Universitaria Senese [European Reference Network (ERN) for Rare Immunodeficiency,Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe
[6] Autoinflammatory and Autoimmune Diseases (RITA) Center] Siena,J)
[7] University of Catania,Department of Ophthalmology and Otolaryngology
[8] Policlinic Hospital,Rheumatology Unit, Department of Medical Sciences
[9] University of Bari,Rheumatology Department
[10] University of Bari,Rheumatology Unit, Department of Biotechnological and Applied Clinical Sciences
[11] Azienda Ospedaliero-Universitaria S. Anna-Ferrara,Rheumatology and Clinical Immunology, Spedali Civili and Department of Clinical and Experimental Sciences
[12] University of Ferrara,Department of Life, Health & Environmental Sciences and Internal Medicine and Nephrology Unit, Department of Medicine
[13] IRCCS Policlinico S. Matteo Fondazione,Clinical and Research Section of Rheumatology and Clinical Immunology
[14] University of Pavia,Rheumatology and Clinical Immunology, Department of Medicine, School of Medicine
[15] University of L’Aquila,Department of Precision Medicine
[16] University of Brescia,Rheumatology Unit, Department of Medical Sciences
[17] University of L’Aquila and ASL Avezzano-Sulmona-L’Aquila,Department of Experimental and Clinical Medicine
[18] San Salvatore Hospital,Department of Medicine, Centre for Inflammatory Diseases, Monash Medical Centre
[19] Fondazione Policlinico Campus Bio-Medico,Unit of Pediatric Rheumatology
[20] University of Rome “Campus Biomedico”,U.O.C. Reumatologia
[21] Università Degli Studi Della Campania Luigi Vanvitelli,Pediatric Clinic
[22] University and AOU of Cagliari,Rheumatology Unit, Department of Medicine
[23] University of Florence,Pediatric Nephrology and Rheumatology Unit
[24] Monash University,Rheumatology Unit
[25] ASST Gaetano Pini-CTO,Rheumatology Unit
[26] Ospedale San Camillo-Forlanini,Department of Translational Medical Sciences, Section of Clinical Immunology
[27] University of Brescia and Spedali Civili Di Brescia,Center for Basic and Clinical Immunology Research (CISI), World Allergy Organization (WAO) Center of Excellence
[28] University of Perugia,Department of Maternal Infantile and Urological Sciences
[29] AOU Policlinic G Martino,Department of Clinical and Experimental Medicine
[30] University of Verona,Department of Woman, Child and of General and Specialized Surgery
[31] Policlinico G. B. Rossi,Medicina Interna
[32] San Giovanni di Dio Hospital,University Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE) “G. D’Alessandro”
[33] University of Naples Federico II,Bioengineering and Biomedical Data Science Lab, Department of Medical Biotechnologies
[34] University of Naples Federico II,Ophthalmology Unit, Department of Medicine, Surgery and Neurosciences
[35] Polo Pontino,Research Center of Systemic Autoinflammatory Diseases and Behçet’s Disease Clinics, Department of Medical Sciences, Surgery and Neurosciences, Rheumatology Unit
[36] Sapienza University of Rome,undefined
[37] University of Catania,undefined
[38] University of Campania “Luigi Vanvitelli”,undefined
[39] Ospedale Fatebenefratelli,undefined
[40] University of Palermo,undefined
[41] University of Siena,undefined
[42] University of Siena,undefined
[43] University of Siena,undefined
[44] Policlinico “Le Scotte”,undefined
来源
Internal and Emergency Medicine | 2023年 / 18卷
关键词
Aphthosis; Pseudofolliculitis; Erythema nodosum; Diagnosis; Autoinflammatory diseases;
D O I
暂无
中图分类号
学科分类号
摘要
Behçet’s disease (BD) is a heterogeneous multifactorial autoinflammatory disease characterized by a plethora of clinical manifestations. Cutaneous lesions are considered hallmarks of the disease. However, their evolution over time and a thorough description are scarcely reported in non-endemic regions. The aim of this study was to detail BD skin manifestations and their evolution over time in Italy, as well as the dermatological prognostic impact of specific cutaneous features in long-standing disease. Data were collected in a double fashion, both retrospectively and prospectively, from the AutoInflammatory Disease Alliance (AIDA) international registry dedicated to BD, between January 2022 and December 2022. A total of 458 Italian patients were included. When assessing skin manifestations course, the constant or sporadic presence or absence of cutaneous involvement between onset and follow-up was considered. Oral ulcers (OU) (88.4%) and genital ulcers (GU) (52.6%), followed by skin involvement (53.7%) represented the most common presenting mucocutaneous manifestations at disease onset. Up to the time of enrolment into the AIDA registry, 411 (93.8%) patients had suffered from OU and 252 (57.9%) from GU; pseudofolliculitis (PF) accounted for the most common skin manifestation (170 patients, 37.1%), followed by erythema nodosum (EN) (102 patients, 22.3%), skin ulcers (9 patients, 2%) and pyoderma gangrenosum (4 patients, 0.9%). A prospective follow-up visit was reported in 261/458 patients; 24/148 (16.2%) subjects with skin involvement as early as BD onset maintained cutaneous lesions for the entire period of observation, while 120 (44.1%) patients suffered from sporadic skin involvement. Conversely, 94/113 (83.2%) with no skin involvement at disease onset did not develop skin lesions thereafter. At follow-up visits, cutaneous involvement was observed in 52 (20%) patients, with a statistically significant association between PF and constant skin involvement (p = 0.031). BD in Italy is characterized by a wide spectrum of clinical presentations and skin manifestations in line with what is described in endemic countries. Patients with skin disease at the onset are likely to present persistent cutaneous involvement thereafter; mucocutaneous lesions observed at the onset, especially PF, could represent a warning sign for future persistent skin involvement requiring closer dermatological care.
引用
收藏
页码:2245 / 2252
页数:7
相关论文
共 313 条
[1]  
Yazici Y(2021)Behçet syndrome Nat Rev Dis Primers 7 67-833
[2]  
Hatemi G(2022)Update on the diagnosis of Behcet's disease Diagnostics (Basel) 13 41-806
[3]  
Bodaghi B(2010)Behcet’s disease: from East to West Clin Rheumatol 29 823-310
[4]  
Cheon JH(2003)Prevalence of Behcet’s disease in Istanbul Turkey Int J Dermatol 42 803-632
[5]  
Suzuki N(2021)Epidemiology and treatment of Behcet's disease in the USA: insights from the rheumatology informatics system for effectiveness (RISE) registry with a comparison with other published cohorts from endemic regions Arthritis Res Ther 23 224-358
[6]  
Ambrose N(2013)Incidence, prevalence and clinical characteristics of Behcet's disease in southern Sweden Rheumatology (Oxford) 52 304-1986
[7]  
Yazici H(2016)Behcet's disease: a comprehensive review with a focus on epidemiology, etiology and clinical features, and management of mucocutaneous lesions J Dermatol 43 620-1039
[8]  
Alibaz-Oner F(2021)Treatment of Behcet's disease: an algorithmic multidisciplinary approach Front Med (Lausanne) 8 349-434
[9]  
Direskeneli H(2022)Skin manifestation as an explaining factor of heterogeneity in Behcet’s disease: a focused analysis in full-blown conditions J Dermatol 49 878797-31
[10]  
Davatch F(2022)Development and implementation of the AIDA international registry for patients with still's disease Front Med (Lausanne) 9 1977-178